Literature DB >> 17606475

Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam.

Catherine M Brignell1, Joe Rosenthal, H Valerie Curran.   

Abstract

Benzodiazepines produce robust impairments of memory alongside global decreases in physiological and subjective arousal. Recently one benzodiazepine (triazolam) has been found to disproportionately impair memory for emotionally arousing material (Buchanan et al., 2003). The extent to which this effect may be mediated by the drug's sedative action is unclear. The present study aimed to assess how pharmacologically decreasing physiological arousal with a benzodiazepine and increasing arousal with a stimulant impact on memory for emotional material. A double-blind placebo controlled trial with 48 volunteers was used to investigate the effects of methylphenidate (40 mg) and Lorazepam (1.5 mg) on incidental memory for emotional material in Cahill and McGaugh's (1995) slide-story task. The slide-story was presented to participants administered either active drug or placebo and retrieval was assessed one week later. Methylphenidate produced stimulant effects and Lorazepam produced sedative effects. Significantly enhanced memory for emotional material was observed in participants given placebo, but not in those given either methylphenidate or Lorazepam. Despite producing opposite effects upon arousal, both methylphenidate and Lorazepam lessen the impact of emotionally arousing material on memory. The effects of Lorazepam add to a growing literature that benzodiazepines may exert their clinical, anxiolytic effects in part via altering emotionaL cognitive function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606475     DOI: 10.1177/0269881107077351

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  11 in total

1.  Acute and long-term effects of adolescent methylphenidate on decision-making and dopamine receptor mRNA expression in the orbitofrontal cortex.

Authors:  Leslie R Amodeo; Eliza Jacobs-Brichford; Matthew S McMurray; Jamie D Roitman
Journal:  Behav Brain Res       Date:  2017-02-14       Impact factor: 3.332

Review 2.  Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors:  M Elizabeth Smith; Martha J Farah
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

3.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

Review 4.  Emotional memory in schizophrenia.

Authors:  Ellen S Herbener
Journal:  Schizophr Bull       Date:  2008-07-15       Impact factor: 9.306

5.  Human genome-guided identification of memory-modulating drugs.

Authors:  Andreas Papassotiropoulos; Christiane Gerhards; Angela Heck; Sandra Ackermann; Amanda Aerni; Nathalie Schicktanz; Bianca Auschra; Philippe Demougin; Eva Mumme; Thomas Elbert; Verena Ertl; Leo Gschwind; Edveena Hanser; Kim-Dung Huynh; Frank Jessen; Iris-Tatjana Kolassa; Annette Milnik; Paolo Paganetti; Klara Spalek; Christian Vogler; Andreas Muhs; Andrea Pfeifer; Dominique J-F de Quervain
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

6.  Methylphenidate as a cognitive enhancer in healthy young people.

Authors:  Silmara Batistela; Orlando Francisco Amodeo Bueno; Leonardo José Vaz; José Carlos Fernandes Galduróz
Journal:  Dement Neuropsychol       Date:  2016 Apr-Jun

7.  Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Brain Behav       Date:  2012-07-23       Impact factor: 2.708

8.  Just How Cognitive Is "Cognitive Enhancement"? On the Significance of Emotions in University Students' Experiences with Study Drugs.

Authors:  Scott Vrecko
Journal:  AJOB Neurosci       Date:  2013-02-07

9.  Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers.

Authors:  Claire Advokat; Mindy Scheithauer
Journal:  Front Neurosci       Date:  2013-05-29       Impact factor: 4.677

Review 10.  Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit.

Authors:  Tangunu Fosi; Maria T Lax-Pericall; Rod C Scott; Brian G Neville; Sarah E Aylett
Journal:  Epilepsia       Date:  2013-12       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.